Why the study?
Does dosage reduction of anticholinergic drugs improve cognitive function in elderly nursing home residents?
Does dosage reduction of anticholinergic drugs improve cognitive function in elderly nursing home residents?
Reducing serum antimuscarinic activity through dosage reduction may improve cognitive function in elderly nursing home residents.
Answers are grounded in this paper and cite their sources.
Supports deprescribing anticholinergics in elderly nursing home residents; extends antimuscarinic burden evidence to RCT cognitive outcomes.
Adverse drug reactions among elderly patients pose a significant clinical problem. The authors used a serum radioreceptor assay [RRA] to quantify drug-induced muscarinic blockade in 34 randomly selected nursing home residents. A random intervention group and the nonintervention control subjects were then retested 4 weeks later. The reduction of serum antimuscarinic activity (as determined by RRA) did relate to changes on several measures of cognitive function. A calculated "antimuscarinic index" lost significance with the RRA following intervention and may have overestimated the impact of a dosage reduction.
No takes yet. Share an insight, caveat, or question.
Tollefson et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: